3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Sarcoma
12
Lymphoma, Large B-Cell, Diffuse
12
Sarcoma, Ewing
4
Lymphoma, B-Cell
4
Recurrence
3
Precursor Cell Lymphoblastic Leukemia-Lymphoma
3
Osteosarcoma
3
Neurofibrosarcoma
3
Lymphoma, Non-Hodgkin
3
Liposarcoma
3
Hodgkin Disease
3
Fibrosarcoma
3
Sarcoma, Synovial
2
Sarcoma, Clear Cell
2
Rhabdomyosarcoma
2
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
2
Neuroblastoma
2
Nerve Sheath Neoplasms
2
Neoplasms, Germ Cell and Embryonal
2
Lymphoma, Follicular
2
Lymphoma
2
Leiomyosarcoma
2
Histiocytoma, Malignant Fibrous
2
Histiocytoma, Angiomatoid Fibrous
2
Hemangiosarcoma
2
Granuloma, Plasma Cell
2
Desmoplastic Small Round Cell Tumor
2
Dermatofibrosarcoma
2
Chondrosarcoma, Extraskeletal Myxoid
2
Burkitt Lymphoma
2
Interventions
pembrolizumab
6
Cetuximab
5
olaparib
3
atezolizumab
3
Injections
3
fludarabine
2
Trastuzumab
2
Docetaxel
2
Cyclophosphamide
2
Bevacizumab
2
zimberelimab
1
zansecimab
1
tocilizumab
1
taxane
1
spartalizumab
1
somatostatin receptor 2
1
ribociclib
1
pralsetinib
1
pertuzumab
1
pegylated granulocyte colony-stimulating factor
1
lenvatinib
1
ipatasertib
1
inavolisib
1
fludarabine phosphate
1
entrectinib
1
encorafenib
1
durvalumab
1
dapagliflozin
1
cemiplimab
1
brigimadlin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Solid Tumors
×
Ifosfamide
×
1 year
×
Clear all
No trials found.